SUCLG1 mutations and mitochondrial encephalomyopathy: a case study and review of the literature

Samira Molaei Ramsheh,Maryam Erfanian Omidvar,Maryam Tabasinezhad,Behnam Alipoor,Tayyeb Ali Salmani,Hamid Ghaedi
DOI: https://doi.org/10.1007/s11033-020-05999-y
IF: 2.7422
2020-11-23
Molecular Biology Reports
Abstract:The mitochondrial encephalomyopathies represent a clinically heterogeneous group of neurodegenerative disorders. The clinical phenotype of patients could be explained by mutations of mitochondria-related genes, notably <i>SUCLG1</i> and <i>SUCLA2</i>. Here, we presented a 5-year-old boy with clinical features of mitochondrial encephalomyopathy from Iran. Also, a systematic review was performed to explore the involvement of <i>SUCLG1</i> mutations in published mitochondrial encephalomyopathies cases. Genotyping was performed by implementing whole-exome sequencing. Moreover, quantification of the mtDNA content was performed by real-time qPCR. We identified a novel, homozygote missense variant chr2: 84676796 A &gt; T (hg19) in the <i>SUCLG1</i> gene. This mutation substitutes Cys with Ser at the 60-position of the SUCLG1 protein. Furthermore, the <i>in-silico</i> analysis revealed that the mutated position in the genome is well conserved in mammalians, that implies mutation in this residue would possibly result in phenotypic consequences. Here, we identified a novel, homozygote missense variant chr2: 84676796 A &gt; T in the <i>SUCLG1</i> gene. Using a range of experimental and in silico analysis, we found that the mutation might explain the observed phenotype in the family.
biochemistry & molecular biology
What problem does this paper attempt to address?